Christine A. Poon - 27 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Christine A. Poon
Issuer symbol
REGN
Transactions as of
27 Aug 2021
Net transactions value
-$9,164,756
Form type
4
Filing time
31 Aug 2021, 16:03:00 UTC
Previous filing
07 Jul 2021
Next filing
20 Sep 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $856,650 +15,000 +892% $57.11* 16,681 27 Aug 2021 Direct
transaction REGN Common Stock Sale $66,262 -100 -0.6% $662.62 16,581 27 Aug 2021 Direct
transaction REGN Common Stock Sale $1,499,533 -2,260 -14% $663.51 14,321 27 Aug 2021 Direct F1
transaction REGN Common Stock Sale $465,094 -700 -4.9% $664.42 13,621 27 Aug 2021 Direct F2
transaction REGN Common Stock Sale $357,948 -538 -3.9% $665.33 13,083 27 Aug 2021 Direct F3
transaction REGN Common Stock Sale $745,371 -1,118 -8.5% $666.70 11,965 27 Aug 2021 Direct F4
transaction REGN Common Stock Sale $1,434,846 -2,150 -18% $667.37 9,815 27 Aug 2021 Direct F5
transaction REGN Common Stock Sale $403,003 -603 -6.1% $668.33 9,212 27 Aug 2021 Direct F6
transaction REGN Common Stock Sale $1,496,534 -2,235 -24% $669.59 6,977 27 Aug 2021 Direct F7
transaction REGN Common Stock Sale $2,311,145 -3,447 -49% $670.48 3,530 27 Aug 2021 Direct F8
transaction REGN Common Stock Sale $1,166,378 -1,737 -49% $671.49 1,793 27 Aug 2021 Direct F9
transaction REGN Common Stock Sale $75,294 -112 -6.2% $672.27 1,681 27 Aug 2021 Direct F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -15,000 -100% $0.000000* 0 27 Aug 2021 Common Stock 15,000 $57.11 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 2,260 shares of Company stock on August 27, 2021 at prices ranging from $663.11 to $663.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
F2 Represents volume-weighted average price of sales of 700 shares of Company stock on August 27, 2021 at prices ranging from $664.00 to $664.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 538 shares of Company stock on August 27, 2021 at prices ranging from $665.07 to $665.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 1,118 shares of Company stock on August 27, 2021 at prices ranging from $666.39 to $666.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 2,150 shares of Company stock on August 27, 2021 at prices ranging from $667.01 to $667.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 603 shares of Company stock on August 27, 2021 at prices ranging from $668.04 to $668.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 2,235 shares of Company stock on August 27, 2021 at prices ranging from $669.17 to $669.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 3,447 shares of Company stock on August 27, 2021 at prices ranging from $670.01 to $670.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 1,737 shares of Company stock on August 27, 2021 at prices ranging from $671.00 to $671.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
F10 Represents volume-weighted average price of sales of 112 shares of Company stock on August 27, 2021 at prices ranging from $672.27 to $672.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
F11 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.